Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
NCT06516653
This study is recruiting at 8 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: Treatment arm: End to side fistula supported with VasQ Control: Standard of care end to side fistula
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- End Stage Renal Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Laminate Medical Technologies
- Last updated on ClinicalTrials.gov
- July 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Fresenius Vascular Care Long Beach · Long Beach, CA
Florida · 1
- Sarasota Memorial Hospital · Sarasota, FL
Georgia · 1
- Grady Memorial Hospital · Atlanta, GA
Massachusetts · 1
- Brigham and Women's Hospital · Boston, MA
Mississippi · 1
- Greenwood Leflore Hospital · Greenwood, MS
South Carolina · 1
- Fresenius Vascular Care Columbia · Columbia, SC
Texas · 1
- Houston Methodist Hospital · Houston, TX
Virginia · 1
- Fairlawn Surgery Center · Roanoke, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.